AMBIRIX Trademark

Trademark Overview


On Friday, April 29, 2005, a trademark application was filed for AMBIRIX with the United States Patent and Trademark Office. The USPTO has given the AMBIRIX trademark a serial number of 78620107. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, December 27, 2013. This trademark is owned by GlaxoSmithKline Biologicals S.A.. The AMBIRIX trademark is filed in the Pharmaceutical Products category with the following description:

HUMAN VACCINES
ambirix

General Information


Serial Number78620107
Word MarkAMBIRIX
Filing DateFriday, April 29, 2005
Status710 - CANCELLED - SECTION 8
Status DateFriday, December 27, 2013
Registration Number3243650
Registration DateTuesday, May 22, 2007
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 6, 2007

Trademark Statements


Goods and ServicesHUMAN VACCINES

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, December 27, 2013
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxoSmithKline Biologicals S.A.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressRixensart B-1330
BE

Party NameGlaxoSmithKline Biologicals S.A.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressRixensart B-1330
BE

Party NameGlaxoSmithKline Biologicals S.A.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRixensart B-1330
BE

Trademark Events


Event DateEvent Description
Friday, December 27, 2013CANCELLED SEC. 8 (6-YR)
Friday, March 15, 2013TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, February 20, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, February 20, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, May 13, 2010TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, October 20, 2009ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, October 20, 2009TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, May 22, 2007REGISTERED-PRINCIPAL REGISTER
Tuesday, March 6, 2007PUBLISHED FOR OPPOSITION
Wednesday, February 14, 2007NOTICE OF PUBLICATION
Tuesday, January 16, 2007LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, January 12, 2007APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, January 11, 2007TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, January 11, 2007CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, January 11, 2007ASSIGNED TO LIE
Monday, December 11, 2006TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, June 29, 2006NON-FINAL ACTION E-MAILED
Thursday, June 29, 2006NON-FINAL ACTION WRITTEN
Thursday, June 15, 2006TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, June 8, 2006CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, June 8, 2006TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, December 12, 2005NON-FINAL ACTION E-MAILED
Monday, December 12, 2005NON-FINAL ACTION WRITTEN
Tuesday, November 29, 2005ASSIGNED TO EXAMINER
Wednesday, May 11, 2005NEW APPLICATION ENTERED IN TRAM

Related Keywords


ambirix vaccines human